Article Text

Download PDFPDF
A novel use of reticulated hyaluronic acid (Healaflow) for hypotony eyes in patients with uveitis
  1. R E Stead1,
  2. Z Juma1,
  3. S Turner1,
  4. L D Jones2,
  5. V C T Sung1
  1. 1Birmingham Midlands Eye Centre, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
  2. 2Royal Stoke University Hospital, UHNM, Newcastle Road, Stoke-on-Trent, ST4 6QG, UK
  1. Correspondence to Velota Sung, Birmingham Midland Eye Centre, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Dudley Road, Birmingham, West Midlands B18 7QH, UK; velota.sung{at}


Persistent ocular hypotony is a complex and ongoing challenge faced in ophthalmology. It can result in early ocular phthisis and associated visual decline, pain and deformity. We present the first case series, in which repeated intracameral injections of highly reticulated hyaluronic acid (Healaflow) have successfully prevented the complications of ocular hypotony in the long term. We believe it is a viable management option that can bring about a significant improvement to the quality of life in this subgroup of patients while avoiding frequent intervention.

  • Glaucoma
  • Intraocular pressure
  • Treatment other

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.